Defined Benefit Plan, Prescription Drug Benefit, Net Periodic Postretirement Benefit Cost, (Increase) Decrease for Subsidy

NamePrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1
Namespacehttp://fasb.org/us-gaap/2020-01-31
Prefixus-gaap
Data typexbrli:monetaryItemType
Period typeduration
Substitution Groupxbrli:item
Balancecredit
NillableTrue
AbstractFalse

Labels

TextLangRoleContainer role
Defined Benefit Plan, Prescription Drug Benefit, Net Periodic Postretirement Benefit Cost, (Increase) Decrease for Subsidyen-UShttp://www.xbrl.org/2003/role/labelhttp://www.xbrl.org/2003/role/link
Amount of (increase) decrease in net periodic benefit cost from government subsidy for prescription drug benefits.en-UShttp://www.xbrl.org/2003/role/documentationhttp://www.xbrl.org/2003/role/link

References

NameValueRole
PublishDate2017-01http://fasb.org/us-gaap/role/tin/taxonomyImplementationNote
Positive_XBRL_ValueEnter a positive XBRL value for decrease in net periodic benefit cost.http://fasb.org/us-gaap/role/tin/taxonomyImplementationNote
Negative_XBRL_ValueEnter a negative XBRL value for increase in net periodic benefit cost.http://fasb.org/us-gaap/role/tin/taxonomyImplementationNote
PublisherFASBhttp://www.xbrl.org/2003/role/disclosureRef
NameAccounting Standards Codificationhttp://www.xbrl.org/2003/role/disclosureRef
Topic715http://www.xbrl.org/2003/role/disclosureRef
SubTopic60http://www.xbrl.org/2003/role/disclosureRef
Section50http://www.xbrl.org/2003/role/disclosureRef
Paragraph3http://www.xbrl.org/2003/role/disclosureRef
Subparagraph(b)http://www.xbrl.org/2003/role/disclosureRef
URIhttp://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964http://www.xbrl.org/2003/role/disclosureRef